Investors in Adaptive Biotechnologies Corp (Symbol: ADPT) saw new options become available this week, for the October 17th expiration. One of the key data points that goes into the price an option ...

In this article, we are going to take a look at where Adaptive Biotechnologies Corporation (NASDAQ:ADPT) stands against other stocks Insiders are selling in March. Wall Street experienced a ...

Fintel reports that on March 21, 2025, Goldman Sachs upgraded their outlook for Adaptive Biotechnologies (NasdaqGS:ADPT) from Neutral to Buy. Analyst Price Forecast Suggests 27.23% Upside As of ...

The Goldman Sachs Group upgraded shares of Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) from a neutral rating to a buy rating in a research report released on Friday, Marketbeat.com reports.

SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...